Evidence map›Paper›PMID 28770176›Full record

ArticleFrontiers in cellular and infection microbiology2017

Inhibition of

Marta Machado, Margarida Sanches-Vaz, João P Cruz, António M Mendes, Miguel Prudêncio

Open access · goldAbstract read
In one paragraph

Article in Frontiers in cellular and infection microbiology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
1.8field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 22 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Novel Harmicines with Improved Potency againstMolecules (Basel, Switzerland) · 2020
    Article
  6. Repurposing Drugs to Fight Hepatic Malaria Parasites.Molecules (Basel, Switzerland) · 2020
    Review
  7. Article
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 1 institution in 1 country.

Marta MachadoFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de LisboaLisboa, Portugal.
Margarida Sanches-VazFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de LisboaLisboa, Portugal.
João P CruziMed.UL-Research Institute for Medicines and Pharmaceutical Sciences, Faculdade de Farmácia da Universidade de LisboaLisboa, Portugal.
António M MendesFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de LisboaLisboa, Portugal.
Miguel PrudêncioFaculdade de Medicina, Instituto de Medicina Molecular, Universidade de LisboaLisboa, Portugal.
University of Lisbon · PT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent WHO guidelines on control of human immunodeficiency virus (HIV) call for the widespread use of antiretroviral (AR) therapy (ART) for people living with HIV. Given the considerable overlap between infections by HIV and

Indexed as

AlkynesAnimalsAntimalarialsAnti-Retroviral AgentsBenzoxazinesCell LineCyclopropanesDisease Models, AnimalHepatocytesHumansMalariaMaleMice, Inbred C57BLNelfinavirNitrilesPlasmodium bergheiAlkynesAntimalarialsAnti-Retroviral AgentsBenzoxazinesCyclopropanesefavirenzetravirineNelfinavirNitrilesPyridazinesPyrimidinesAIDSantiretroviralsantiretroviral therapyHIVliver stagemalariaPlasmodium

Identifiers

PMID28770176
PMCPMC5515864
OpenAlexW2736747275

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.